NanoVibronix, Inc. (NAOV)

Market Cap	5.39M
Revenue (ttm)	1.00M
Net Income (ttm)	-4.96M
Shares Out	4.57M
EPS (ttm)	-3.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	144,203
Open	1.12
Previous Close	1.37
Day's Range	1.12 - 1.24
52-Week Range	0.73 - 11.34
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2023

About NAOV

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat p...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: NAOV

Financial Performance

In 2022, NanoVibronix's revenue was $752,000, a decrease of -55.63% compared to the previous year's $1.70 million. Losses were -$5.45 million, -61.85% less than in 2021.